Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Szarewski

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Current Oncology Reports|August 15, 2012
HPV vaccination and cervical cancerAnne Szarewski
Contraception|August 6, 2013
Randomized trial of the effect of tailored versus standard use of the combined oral contraceptive pill is not the second largest RCTAnne Szarewski
Expert Opinion on Biological Therapy|February 6, 2010
HPV vaccine: CervarixAnne Szarewski
The Lancet. Oncology|October 4, 2005
Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancerAnne Szarewski
Lancet (London, England)|August 7, 2007
Cervical screening by visual inspection with acetic acidAnne Szarewski
The Journal of Family Planning and Reproductive Health Care|April 10, 2009
Sisters doing it for themselvesAnne Szarewski
The Journal of Family Health Care|May 24, 2006
Hormonal contraception: recent advancesAnne Szarewski
Expert Review of Vaccines|August 10, 2012
Cervarix®: a bivalent vaccine against HPV types 16 and 18, with cross-protection against other high-risk HPV typesAnne Szarewski
The Practitioner|June 26, 2003
The combined contraceptive pillAnne Szarewski
The Journal of Family Planning and Reproductive Health Care|April 2, 2011
Ushering in a new era: human papillomavirus (HPV) testing comes to the NHS Cervical Screening ProgrammeAnne Szarewski
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Current Oncology Reports|August 15, 2012
HPV vaccination and cervical cancerAnne Szarewski
Contraception|August 6, 2013
Randomized trial of the effect of tailored versus standard use of the combined oral contraceptive pill is not the second largest RCTAnne Szarewski
Expert Opinion on Biological Therapy|February 6, 2010
HPV vaccine: CervarixAnne Szarewski
The Lancet. Oncology|October 4, 2005
Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancerAnne Szarewski
Lancet (London, England)|August 7, 2007
Cervical screening by visual inspection with acetic acidAnne Szarewski
The Journal of Family Planning and Reproductive Health Care|April 10, 2009
Sisters doing it for themselvesAnne Szarewski
The Journal of Family Health Care|May 24, 2006
Hormonal contraception: recent advancesAnne Szarewski
Expert Review of Vaccines|August 10, 2012
Cervarix®: a bivalent vaccine against HPV types 16 and 18, with cross-protection against other high-risk HPV typesAnne Szarewski
The Practitioner|June 26, 2003
The combined contraceptive pillAnne Szarewski
The Journal of Family Planning and Reproductive Health Care|April 2, 2011
Ushering in a new era: human papillomavirus (HPV) testing comes to the NHS Cervical Screening ProgrammeAnne Szarewski
Pageof 6